pI: 8.1133 |
Length (AA): 729 |
MW (Da): 81999 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_133402)
Species | Accession | Gene Product |
---|---|---|
Brugia malayi | Bm1_56715 | SH2 domain containing protein |
Caenorhabditis elegans | CELE_Y48G1C.2 | Protein CSK-1 |
Drosophila melanogaster | Dmel_CG42317 | C-terminal Src kinase |
Echinococcus granulosus | EgrG_000588500 | tyrosine protein kinase csk |
Echinococcus granulosus | EgrG_000588200 | tyrosine protein kinase csk |
Echinococcus granulosus | EgrG_000588400 | tyrosine protein kinase csk |
Echinococcus granulosus | EgrG_000342000 | c src tyrosine kinase |
Echinococcus multilocularis | EmuJ_000588200 | tyrosine protein kinase csk |
Echinococcus multilocularis | EmuJ_000588100 | tyrosine protein kinase csk |
Echinococcus multilocularis | EmuJ_000588500 | tyrosine protein kinase csk |
Echinococcus multilocularis | EmuJ_000588400 | tyrosine protein kinase csk |
Echinococcus multilocularis | EmuJ_000342000 | c src tyrosine kinase |
Homo sapiens | ENSG00000103653 | c-src tyrosine kinase |
Loa Loa (eye worm) | LOAG_09906 | SH2 domain-containing protein |
Loa Loa (eye worm) | LOAG_13069 | TK/CSK protein kinase |
Mus musculus | ENSMUSG00000032312 | c-src tyrosine kinase |
Onchocerca volvulus | OVOC1531 |
|
Schistosoma japonicum | Sjp_0202670 | Tyrosine-protein kinase CSK, putative |
Schistosoma mansoni | Smp_125360 | tyrosine kinase |
Schmidtea mediterranea | mk4.004443.00 | CSK-1 |
Schmidtea mediterranea | mk4.002065.04 | CSK-1 |
Schmidtea mediterranea | mk4.002330.02 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | c-src tyrosine kinase | Compounds | References |
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Rattus norvegicus | Jak1 protein | 210 aa | 24.4% | 270 aa | Compounds | References |
Sus scrofa | Casein kinase I isoform alpha | 125 aa | 27.8% | 126 aa | Compounds | References |